Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss

NCT01599130 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Peginterferon alfa-2a

Sponsor

Sun Yat-sen University